内科理论与实践 ›› 2023, Vol. 18 ›› Issue (02): 124-127.doi: 10.16138/j.1673-6087.2023.02.013
收稿日期:
2022-06-17
出版日期:
2023-04-25
发布日期:
2023-05-15
通讯作者:
倪磊 E-mail:
GAO Yulian, FENG Yun, NI Lei()
Received:
2022-06-17
Online:
2023-04-25
Published:
2023-05-15
中图分类号:
高玉莲, 冯耘, 倪磊. 糖尿病人群中耐药革兰阴性菌血流感染的研究进展[J]. 内科理论与实践, 2023, 18(02): 124-127.
GAO Yulian, FENG Yun, NI Lei. Research progress of drug-resistant gram-negative bacteria bloodstream infection in diabetic population[J]. Journal of Internal Medicine Concepts & Practice, 2023, 18(02): 124-127.
[1] | Hu FP. China Antimicrobial Surveillance Network, the results of bacterial resistance in 2021[DB/OL]. 2022. https://www.chinets.com/Document. |
[2] |
Babiker A, Clarke LG, Saul M, et al. Changing epidemiology and decreased mortality associated with carbapenem-resistant Gram-negative bacteria, 2000-2017[J]. Clin Infect Dis, 2021, 73(11): e4521-e4530.
doi: 10.1093/cid/ciaa1464 URL |
[3] |
Nanditha A, Ma RC, Ramachandran A, et al. Diabetes in Asia and the Pacific: implications for the global epidemic[J]. Diabetes Care, 2016, 39(3): 472-485.
doi: 10.2337/dc15-1536 pmid: 26908931 |
[4] | 鲍强, 杨荣礼, 徐敏, 等. 糖尿病合并血流感染耐药性的相关性[J]. 临床与病理杂志, 2021, 41(5): 1064-1074. |
[5] |
Huang CH, Chiu CH, Chen IW, et al. Antimicrobial resistance and outcomes of community-onset bacterial bloodstream infections in patients with type 2 diabetes[J]. J Glob Antimicrob Resist, 2018, 15: 271-276.
doi: 10.1016/j.jgar.2018.08.008 URL |
[6] | Shaik S, Ranjan A, Tiwari SK, et al. Comparative genomic analysis of globally dominant ST131 clone with other epidemiologically successful extraintestinal pathogenic Escherichia coli (ExPEC) lineages[J]. MBio, 2017, 8(5): e01596-e01617. |
[7] |
Daga AP, Koga VL, Soncini JGM, et al. Escherichia coli bloodstream infections in patients at a university hospital[J]. Front Cell Infect Microbiol, 2019, 9: 191.
doi: 10.3389/fcimb.2019.00191 URL |
[8] |
Isendahl J, Giske CG, Hammar U, et al. Temporal dynamics and risk factors for bloodstream infection with extended-spectrum β-lactamase-producing bacteria in previously-colonized individuals[J]. Clin Infect Dis, 2018, 68(4): 641-649.
doi: 10.1093/cid/ciy539 URL |
[9] |
Tchesnokova V, Riddell K, Scholes D, et al. The uropathogenic Escherichia coli subclone sequence type 131-H30 is responsible for most antibiotic prescription errors at an urgent care clinic[J]. Clin Infect Dis, 2019, 68(5): 781-787.
doi: 10.1093/cid/ciy523 pmid: 29961840 |
[10] | Harada S, Aoki K, Yamamoto S, et al. Clinical and molecular characteristics of Klebsiella pneumoniae isolates causing bloodstream infections in Japan[J]. J Clin Microbiol, 2019, 57(11): e01206-e01219. |
[11] |
Liao WC, Chung WS, Lo YC, et al. Changing epidemiology and prognosis of nosocomial bloodstream infection: a single-center retrospective study in Taiwan[J]. J Microbiol Immunol Infect, 2022, 55(6 Pt 2):1293-1300.
doi: 10.1016/j.jmii.2021.09.015 URL |
[12] |
Cheng CY, Kung CT, Chen FC, et al. Impact of prior statin use on mortality in patients with type 2 diabetes mellitus and bloodstream infection[J]. J Int Med Res, 2019, 47(8): 3636-3647.
doi: 10.1177/0300060519856137 URL |
[13] |
Leung CH, Liu CP. Diabetic status and the relationship of blood glucose to mortality in adults with carbapenem-resistant Acinetobacter baumannii complex bacteremia[J]. J Microbiol Immunol Infect, 2019, 52(4): 654-662.
doi: 10.1016/j.jmii.2018.06.005 URL |
[14] |
Jung JS, Hamacher C, Gross B, et al. Evaluation of a semiquantitative matrix-assisted laser desorption ionization-time of flight mass spectrometry method for rapid antimicrobial susceptibility testing of positive blood cultures[J]. J Clin Microbiol, 2016, 54(11): 2820-2824.
pmid: 27629893 |
[15] |
Giacobbe DR, Giani T, Bassetti M, et al. Rapid microbiological tests for bloodstream infections due to multidrug resistant Gram-negative bacteria: therapeutic implications[J]. Clin Microbiol Infect, 2020, 26(6): 713-722.
doi: 10.1016/j.cmi.2019.09.023 URL |
[16] |
Perez KK, Olsen RJ, Musick WL, et al. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia[J]. J Infect, 2014, 69(3): 216-225.
doi: 10.1016/j.jinf.2014.05.005 pmid: 24841135 |
[17] | 马丽平, 崔北辰, 关岚, 等. 2型糖尿病患者发生急性血流感染的预测指标分析[J]. 中国医刊, 2021, 56(9): 972-975. |
[18] | Gao Q, Li Z, Mo X, et al. Combined procalcitonin and hemogram parameters contribute to early differential diagnosis of Gram-negative/Gram-positive bloodstream infections[J]. J Clin Lab Anal, 2021, 35(9):e23927. |
[19] | 耿男, 庞燕, 张静雯, 等. 血清降钙素原诊断成人革兰阴性菌血流感染价值的Meta分析[J]. 国际检验医学杂志, 2021, 42(23): 2822-2829. |
[20] | 侯钧, 张栋珉, 马瑜珊, 等. 糖尿病合并血流感染的病原学特征及预后危险因素分析[J]. 重庆医学, 2022, 51(15): 2622-2627. |
[21] |
Yo CH, Lee MT, Gi WT, et al. Prognostic determinants of community-acquired bloodstream infection in type 2 diabetic patients in ED[J]. Am J Emerg Med, 2014, 32(12):1450-1454.
doi: 10.1016/j.ajem.2014.08.071 URL |
[22] |
Falcone M, Bassetti M, Tiseo G, et al. Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae[J]. Crit Care, 2020, 24(1): 29.
doi: 10.1186/s13054-020-2742-9 |
[23] |
Hauck C, Cober E, Richter SS, et al. Spectrum of excess mortality due to carbapenem-resistant Klebsiella pneumoniae infections[J]. Clin Microbiol Infect, 2016, 22(6): 513-519.
doi: 10.1016/j.cmi.2016.01.023 URL |
[24] | Zhang Y, Chen XL, Huang AW, et al. Mortality attributable to carbapenem-resistant Pseudomonas aeruginosa bacteremia: a meta-analysis of cohort studies[J]. Emerg Microbes Infect, 2016, 5(3): e27. |
[25] | Sabino S, Soares S, Ramos F, et al. A cohort study of the impact of carbapenem-resistant enterobacteriaceae infections on mortality of patients presenting with sepsis[J]. MSphere, 2019, 4(2): e00052-e00119. |
[26] |
Hu F, Guo Y, Yang Y, et al. Resistance reported from China Antimicrobial Surveillance Network(CHINET) in 2018[J]. Eur J Clin Microbiol Infect Dis, 2019, 38(12):2275-2281.
doi: 10.1007/s10096-019-03673-1 |
[27] |
甄思思, 冯四洲. 头孢他啶-阿维巴坦在耐药菌感染中的临床应用研究进展[J]. 中国感染与化疗杂志, 2021, 21(6): 752-758.
doi: 10.16718/j.1009-7708.2021.06.025 |
[28] |
Giannella M, Bartoletti M, Gatti M, et al. Advances in the therapy of bacterial bloodstream infections[J]. Clin Microbiol Infect, 2020, 26(2): 158-167.
doi: 10.1016/j.cmi.2019.11.001 URL |
[29] | 翟群超, 叶山东. 2型糖尿病合并血流感染研究进展[J]. 安徽医学, 2016, 37(9): 1176-1178. |
[30] |
Trevelin SC, Carlos D, Beretta M, et al. Diabetes mellitus and sepsis[J]. Shock, 2017, 47(3): 276-287.
doi: 10.1097/SHK.0000000000000778 pmid: 27787406 |
[31] |
Pearson-Stuttard J, Blundell S, Harris T, et al. Diabetes and infection: assessing the association with glycaemic control in population-based studies[J]. Lancet Diabetes Endocrinol, 2016, 4(2):148-158.
doi: 10.1016/S2213-8587(15)00379-4 URL |
[32] |
Critchley JA, Carey IM, Harris T, et al. Glycemic control and risk of infections among people with type 1 or type 2 diabetes in a large primary care cohort study[J]. Diabetes Care, 2018, 41(10): 2127-2135.
doi: 10.2337/dc18-0287 pmid: 30104296 |
[33] |
Sato J, Kanazawa A, Watada H. Type 2 diabetes and bacteremia[J]. Ann Nutr Metab, 2017, 71 Suppl 1: 17-22.
doi: 10.1159/000479919 pmid: 28950280 |
[34] |
Stoudt K, Chawla S. Don’t sugar coat it[J]. J Intensive Care Med, 2019, 34(11-12):889-896.
doi: 10.1177/0885066618801748 pmid: 30309291 |
[35] |
Abdelmalak BB, Lansang MC. Revisiting tight glycemic control in perioperative and critically ill patients: when one size may not fit all[J]. J Clin Anesth, 2013, 25(6):499-507.
doi: 10.1016/j.jclinane.2012.09.006 pmid: 24008187 |
[36] |
Yamada T, Shojima N, Noma H, et al. Glycemic control, mortality, and hypoglycemia in critically ill patients[J]. Intensive Care Med, 2017, 43(1):1-15.
doi: 10.1007/s00134-016-4523-0 URL |
[37] | American Diabetes Association. Classification and diagnosis of diabetes: standards of medical care in diabetes-2020[J]. Diabetes Care, 2020, 43 Suppl 1:S14-S31. |
[38] |
Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016[J]. Intensive Care Med, 2017, 43(3): 304-377.
doi: 10.1007/s00134-017-4683-6 pmid: 28101605 |
[1] | 张梦潇, 韦晓, 张少红, 陈国芳, 刘超. 生长分化因子15:减重治疗的新靶点[J]. 内科理论与实践, 2023, 18(02): 128-130. |
[2] | 中华医学会内分泌学分会. 老年与儿童青少年糖尿病人群新型冠状病毒感染临床应对指南[J]. 内科理论与实践, 2023, 18(01): 10-12. |
[3] | 张梦潇, 孙烁烁, 韦晓, 张少红, 陈国芳, 刘超. 生酮饮食诱导db/db小鼠肝脏脂肪沉积[J]. 内科理论与实践, 2023, 18(01): 56-63. |
[4] | 卜凡玉 郭晓峰 徐鹏 王进 薛明宇 潘筱云. 抗生素骨水泥联合其他综合干预措施治疗糖尿病足骨髓炎[J]. 组织工程与重建外科杂志, 2022, 18(4): 328-. |
[5] | 缪雅, 刘丽丽, 侯田志超, 严青华, 庞怡, 吴春晓, 程旻娜, 施燕, 黎衍云, 田景琰. 上海糖尿病前期人群恶性肿瘤发病风险分析[J]. 内科理论与实践, 2022, 17(06): 435-440. |
[6] | 阮铭, 侯田志超, 王海燕, 黎衍云, 周冰心, 包超慧, 秦洁洁, 王宇光, 方海, 朱伟嵘, 田景琰. 糖尿病前期“治未病”的几何深度学习与计算医学研究展望[J]. 内科理论与实践, 2022, 17(06): 475-481. |
[7] | 秦雪, 郭华, 张云云, 崔小川. C1q肿瘤坏死因子相关蛋白3与代谢相关疾病的研究进展[J]. 内科理论与实践, 2022, 17(06): 482-485. |
[8] | 许晴, 邵慧英, 陈帅, 全进伟, 周清芬, 王敏慧. 延续健康教育和指导对干预2型糖尿病患者冠状动脉斑块进展的影响[J]. 内科理论与实践, 2022, 17(04): 330-333. |
[9] | 高晶晶, 高艳虹. 早发2型糖尿病流行病学、临床特征及病因机制的研究进展[J]. 内科理论与实践, 2022, 17(04): 344-348. |
[10] | 孙洪平, 陈国芳, 刘超. 植物性饮食与2型糖尿病的研究进展[J]. 内科理论与实践, 2022, 17(04): 349-352. |
[11] | 中华医学会内分泌学分会. 新型冠状病毒肺炎疫情下糖尿病管理专家建议[J]. 诊断学理论与实践, 2022, 21(02): 136-138. |
[12] | 卞秀娟, 包志瑶, 陈虹, 承璐潇, 石宝平. 血流感染耐碳青霉烯类肺炎克雷伯菌患者的死亡危险因素分析[J]. 内科理论与实践, 2022, 17(01): 73-77. |
[13] | 李丽, 朱咏臻, 周敏, 钱嘉, 方丽莉. 2017年至2021年上海嘉定区某医院多重耐药菌分析[J]. 诊断学理论与实践, 2022, 21(01): 62-67. |
[14] | 陈煦阳, 顾卫琼. 胰岛素自身抗体临床检测应用局限及对策研究进展[J]. 诊断学理论与实践, 2022, 21(01): 95-98. |
[15] | 王永灵 廖明娟 李琰 蒉纲. 阳和汤加减内服结合负压技术治疗糖尿病足[J]. 组织工程与重建外科杂志, 2021, 17(5): 426-. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||